Industrials EagleNXT Joint Venture “ThirdEye USA” Selected to Participate in EXTiC 26-2 Counter-UAS Experimentation Event July 27, 2026
Health Kura Oncology Reports Durable Clinical Activity of Darlifarnib Plus Cabozantinib in Cabozantinib-Naïve Clear Cell Renal Cell Carcinoma Patients at KCRS 2026 July 27, 2026
Biotech IDEAYA Biosciences Announces IDE892, a Potential Best-in-Class MTA-Cooperative PRMT5 Inhibitor, Initiates Part 2 Monotherapy Expansion in the Phase 1/2 Study in MTAP-Deleted Pancreatic and Lung Cancers July 27, 2026
Biotech Profusa Announces Key Management Changes and Signing of Non-Binding Term Sheet for the Acquisition of a Commercial Stage Diagnostics Company July 27, 2026
Search
editorial
July 27, 2026
July 27, 2026
July 27, 2026
July 27, 2026
July 27, 2026
July 27, 2026
July 27, 2026
July 27, 2026
July 27, 2026
July 27, 2026
